Serotonin (5-HT) correlates with Adiponectin in overweight patients

Claus Muss¹, Thomas Endler^2
1International Research Group for Applied Preventive Medicine (I-GAP), Vienna, Austria ²Labor Endler, Vienna, Austria

Korespondenční autor: Claus Muss (profmuss@gmail.com)

ISSN 1804-7181 (On-line)

Full verze:

Submitted:20. 3. 2013
Accepted: 16. 7. 2013
Published online: 30. 12. 2013

Summary

We examined the relationship of two neurohormones with neuroendocrine impact (serotonin /5-HT/ and adiponectin) under standardized clinical conditions in an overweight cohort. Adiponectin was measured in serum and Serotonin was determined in the second morning urine samples. Serotonin correlated positively with adiponectin in our investigation Srho (+0.303; p=0.03). As high adiponectin level corresponds with a low risk of Insulin resistance our findings refer to possible improvement of prediabetic conditions in overweight patients tracking peripheral serotonin circulation. Further clinical evidence is mandatory to verify the effects of 5-HT in patients with metabolic syndrome.

Keywords: serotonin (5-hydroxytryptamine – 5-HT); adiponectin; overweight patients; insulin secretion

Literatura

1. Baumgartner A, Gschwend S, Stöckli R, Battegay E, Zimmerli L (2012). Identification and clinical use of the Metabolic Syndrome. Praxis 23. 101/11: 707–713.
2. Díez JJ, Iglesias P (2003). The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 148/3: 293–300.
3. Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, Skelin M, Jevsek M, Fink H, Rupnik M, Walther DJ (2009). Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 7/10.
4. Ukkola O, Santaniemi M (2002). Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med. 80/11: 696–702.
5. Wesolowska A (2002). In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors. Polish Journal of Pharmacology. 54/4: 327–341.
6. Wurtman RJ, Wurtman JJ (1995). Brain serotonin, carbohydrate-craving, obesity and depression. Obesity Research. 3(Suppl. 4): 477–480.
7. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7/8: 941–946.
8. Young SN (2007). How to increase serotonin in the human brain without drugs. Rev Psychiatr Neurosci. 32/6: 394–399.
9. Zhu N, Pankow JS, Ballantyne CM, Couper D, Hoogeveen RC, Pereira M, Duncan BB, Schmidt MI(2010). High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J Clin Endocrinol Metab. 95/11: 5097–5104.